Questex Acquires The Conference Forum and Versalinx Global Events
November 4, 2025
Questex has acquired life-sciences-focused event companies The Conference Forum and Versalinx Global Events to expand its healthcare and life sciences events and media portfolio. The acquisitions add specialty conferences, market-research and competitive-intelligence events, and complementary databases and teams to Questex's Fierce Healthcare & Life Sciences platform.
- Buyers
- Questex
- Targets
- The Conference Forum, Versalinx Global Events
- Industry
- Media & Entertainment
- Location
- New York, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Questex Acquires the Spa Industry Association
June 20, 2021
Healthcare Services
Questex, a New York-based information services and events company, acquired the Spa Industry Association, a for‑profit organization serving the spa and medical spa industries. The acquisition strengthens Questex's Wellness vertical by adding membership, education and industry‑event capabilities to expand its reach into spa, beauty, fitness and related markets.
-
Veranex (backed by Summit Partners) Forms Platform and Acquires Ximedica, Quartesian, and Boston Healthcare Associates
June 16, 2021
Healthcare Services
Veranex, formed in partnership with growth investor Summit Partners, launched a concept-to-commercialization medtech services platform and acquired three complementary companies: Ximedica, Quartesian, and Boston Healthcare Associates. The combined business brings design and engineering, clinical data, regulatory, and market-access/HEOR capabilities together to create an integrated, global medtech service provider.
-
Questex Acquires Digital Signage Expo Assets from Exponation
March 25, 2021
Media & Entertainment
Questex has acquired the live and digital assets of Digital Signage Expo from Exponation LLC, including trademarks, websites, domain names, databases and attendee/vendor lists. The acquisition, executed by Questex (a MidOcean Partners–owned platform), expands Questex’s events and technology portfolio as an add-on to its experience-economy offerings.
-
Accelmed Partners II and Lauxera Capital Invest in Veranex
November 14, 2022
Healthcare Services
Veranex has received strategic growth investments from Accelmed Partners II and Lauxera Capital Partners, joining existing investor Summit Partners, which retains majority ownership. The investments — terms undisclosed — will support Veranex’s continued global expansion and development of its integrated, tech‑enabled medical technology product development services; Uri Geiger (Accelmed) and Samuel Levy (Lauxera) joined Veranex’s board.
-
Truelink Capital Acquires GES from Viad Corp
October 21, 2024
Marketing & Advertising
Truelink Capital has acquired GES, the global exhibition and event business, from Viad Corp in a transaction that closed Dec. 31, 2024. The divestiture separates GES from Viad so Viad can relaunch as Pursuit, while Truelink intends to operate GES as a standalone platform to invest in capabilities, technology and international expansion.
-
Veranex Acquires Medidee to Expand European MedTech Capabilities
September 20, 2022
Healthcare Services
Veranex has acquired Medidee, a Lausanne-based MedTech regulatory and clinical consultancy, expanding Veranex's footprint and capabilities across Europe, India and APAC. The deal strengthens Veranex’s regulatory affairs, clinical development, and quality assurance services for medical device and in vitro diagnostic clients; financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.